Edition:
United States

Profile: Shenzhen Salubris Pharmaceuticals Co Ltd (002294.SZ)

002294.SZ on Shenzhen Stock Exchange

28.70CNY
18 Jan 2017
Change (% chg)

¥-0.08 (-0.28%)
Prev Close
¥28.78
Open
¥28.78
Day's High
¥29.05
Day's Low
¥28.61
Volume
1,126,835
Avg. Vol
3,325,743
52-wk High
¥31.13
52-wk Low
¥23.12

SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. is a China-based company engaged in the research, development, manufacture and sales of pharmaceuticals. The Company provides two categories of products: pharmaceutical preparation and bulk drugs. The Company's medicines for cardiovascular diseases include clopidogrel bisulfate tablets, benazepril hydrochloride tablets and pamidronate disodium for injection. The Company's antibiotics include cefepime hydrochloride for injection, cefuroxime sodium for injection, cefoxitin sodium for injection and others. The Company's bulk drugs include cefepime hydrochloride, cefuroxime sodium, cefoxitin sodium and others. The Company distributes the products within domestic market.

Company Address

Shenzhen Salubris Pharmaceuticals Co Ltd

F37, Main Building,Chegong Templ
Lvgem NEO Square,No.6009 Shennan
Futian District
SHENZHEN   GNG   518040
P: +86755.83867888
F: +86755.83867338

Company Web Links